Production of antineutrophil cytoplasm antibodies derived from circulating B cells in patients with systemic vasculitis

Clinical and Experimental Immunology

Volumn 132, Issue 1, 2003, Pages 174-179

  Clayton, A R ^a   Savage, C O S ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

ANCA; B cells; Systemic vasculitis; T cells

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; TETANUS ANTIBODY; TETANUS TOXOID;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; MALE; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SYSTEMIC VASCULITIS; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; B-LYMPHOCYTES; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOBLASTIN; PEROXIDASE; SERINE ENDOPEPTIDASES; TETANUS TOXOID; VASCULITIS;

EID: 0037387290     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02111.x     Document Type: Article

References (24)

1. Hewins P, Cohen Tervaert JW, Savage COS, Kallenberg CGM. Is Wegener's granulomatosis an autoimmune disease? Curr Opin Rheumatol 2000; 12:3-10.
2. Hagen EC, Daha MR, Hermans J et al. Diagnostic value of standardized assays for anti-neutrophil cytpolasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998; 53:743-53.
3. Savage COS. Interactions between leukocytes, the vascular endothelium and autoantibodies in the development of systemic vasculitis. Ann Med Interne 1993; 144:353-6.
4. Brouwer E, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Immunohistopathology of renal biopsies in Wegener's granulomatosis (WG): clues to its pathogenesis? Kidney Int 1991; 39:1055.
5. Gephardt GN, Ahmad M, Tubbs RR. Pulmonary vasculitis (Wegener's granulomatosis). Immunohistochemical study of T and B cell markers. Am J Med 1983; 74:700-4.
6. Rubin LA, Kurman CC, Fritz ME et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135:3172-7.
7. Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross WL. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity. Arthritis Rheum 1992; 35:1088-96.
8. King WJ, Brooks CJ, Holder R, Hughes P, Adu D, Savage COS. T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission. Clin Exp Immunol 1998; 112:539-46.
9. Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CGM. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 1994; 98:448-53.
10. Griffith ME, Coulthart A, Pusey CD. T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clin Exp Immunol 1996; 103:253-8.
11. Simpson IJ, Skinner MA, Geursen A et al. Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor Vb2 gene usage in microscopic polyarteritis. Clin Exp Immunol 1995; 101:220-6.
12. Giscombe R, Grunewald J, Nityanand S, Lefvert AK. T cell receptor (TCR) V gene usage in patients with systemic necrotising vasculitis. Clin Exp Immunol 1995; 101:213-9.
13. Scherer MT, Kappler JW, Marrack P. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol 1993; 9:101-28.
14. Grunewald J, Halapi E, Wahlström J et al. T-cell expansions with conserved T-cell receptor b chain motifs in the peripheral blood of HLA-DRB1*0401 positive patients with necrotising vasculitis. Blood 1998; 92:3737-44.
15. Csernok E, Trabandt A, Müller A et al. Cytokine profiles in Wegener's granulomatosis. Predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 1999; 42:742-50.
16. + T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 1998; 160:3602-9.
17. Müller A, Trabandt A, Gloeckner-Hofmann K et al. Localized Wegener's granulomatosis: predominance of CD26 and IFN-γ expression. J Pathol 2000; 192:113-20.
18. Balding CEJ, Howie AJ, Drake-Lee AB, Savage COS. Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis. Clin Exp Immunol 2001; 125:332-9.
19. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthritis Rheum 1994; 37:187-92.
20. Vanderheyde N, Verhasselt V, Goldman M, Willems F. Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 1999; 67:1342-7.
21. Lane HC, Volkman DJ, Whalen G, Fauci AS. In vitro antigen-induced, antigen-specific antibody production in man. J Exp Med 1981; 154:1043-57.
22. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumour necrosis factor α. J Exp Med 1994; 179:1109-18.
23. Mathieson PW, Lockwood CM, Oliveira DBG. T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Immunol Immunopathol 1992; 63:135-41.
24. van der Geld YM, Huitema MG, Franssen CFM, van der Zee R, Limburg PC, Kallenberg CGM. In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 2000; 122:504-13.